The method of transporting therapeutic agents to specific targets in the body.Drug delivery is the science of transporting therapeutic agents to specific targets in the body, maximizing efficacy while minimizing side effects. It involves designing carriers — such as nanoparticles, implants, or microneedles — that control the release, timing, and location of a drug. The field is critical for treating diseases like cancer, where targeted delivery can spare healthy tissue, and for chronic conditions requiring sustained medication levels.
The concept of controlled drug release dates back to the 1950s with the development of sustained-release oral formulations. The modern era of targeted delivery began in the 1970s with liposomes, and the first FDA-approved nanoparticle drug (Doxil) appeared in 1995.
Drug delivery systems work by encapsulating or binding the drug to a carrier that protects it from degradation, controls its release rate, and directs it to the desired tissue. This can be achieved through passive targeting (e.g., nanoparticles accumulating in tumors due to leaky blood vessels) or active targeting (e.g., surface ligands binding to specific cell receptors). Release mechanisms include diffusion, degradation of the carrier, or external triggers like pH, temperature, or magnetic fields. Implantable devices can provide controlled, long-term release, while microneedles offer painless transdermal delivery.
Drug delivery is used in chemotherapy (e.g., liposomal doxorubicin), vaccines (mRNA in lipid nanoparticles), insulin pumps, and drug-eluting stents. It is also central to gene therapy, where viral or non-viral vectors deliver therapeutic genes to specific cells.
Some drug delivery systems use magnetic nanoparticles that can be guided to a tumor by an external magnet, concentrating the drug exactly where it's needed and reducing systemic exposure.







